Singleton Mark Leonard

Insider profile

Singleton Mark Leonard's trades of Bioventus Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-04-15 2025-04-11 PlS Planned sale
28,558 -18.8%
300.54
US$1,220,198
28,558 -18.8% 300.54 US$1,220,198
2025-03-25 2025-03-24 PlS Planned sale
36,754 -40.7%
25.32
US$3,134,722
36,754 -40.7% 25.32 US$3,134,722
2025-03-24 2025-03-24 PrS Proposed sale
67,903
148.01
US$989,639
67,903 148.01 US$989,639
2025-02-20 2025-02-18 PlS Planned sale
6,498 -5.2%
10.19
US$66,215
6,498 -5.2% 10.19 US$66,215
2024-12-26 2024-12-23 PlS Planned sale
10,733 -9.3%
10.53
US$113,018
10,733 -9.3% 10.53 US$113,018
2024-12-23 2024-12-23 PrS Proposed sale
19,000
11.15
US$211,850
19,000 11.15 US$211,850
2024-06-25 2024-06-21 PlS Planned sale
9,219 -9.8%
5.57
US$51,350
9,219 -9.8% 5.57 US$51,350
2024-06-21 2024-06-17 PlS Planned sale
13,753 -17.9%
5.84
US$80,318
13,753 -17.9% 5.84 US$80,318
2024-04-15 2024-04-11 PlS Planned sale
4,000 -10.3%
4.75
US$19,000
4,000 -10.3% 4.75 US$19,000
2024-04-11 2024-04-11 PrS Proposed sale
38,000
5.21
US$197,980
38,000 5.21 US$197,980
2024-03-25 2024-03-22 PlS Planned sale
5,541 -17.8%
5.39
US$29,853
5,541 -17.8% 5.39 US$29,853
2023-03-27 2023-03-24 PlS Planned sale
6,044 -32.5%
1.27
US$7,676
6,044 -32.5% 1.27 US$7,676